Erythropoietin and oxidative stress

Current Neurovascular Research

Volumn 5, Issue 2, 2008, Pages 125-142

  Maiese, Kenneth ^a   Zhao, Zhong Chong ^a   Hou, Jinling ^a   Yan, Chen Shang ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Alzheimer's disease; Angiogenesis; Apoptosis; Cancer; Cardiac; Caspases; Diabetes; Endothelial; Erythropoietin; Forkhead; FoxO; GSK 3 ; Inflammation; Mitochondria; NF B; Renal; STATs; Wnt

Indexed keywords

CASPASE; ERYTHROPOIETIN; FORKHEAD TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR; WNT PROTEIN;

BLOOD VESSEL INJURY; CARDIOVASCULAR EFFECT; DIABETES MELLITUS; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNE RESPONSE; METABOLIC DISORDER; MODULATION; NEOPLASM; NERVE DEGENERATION; NERVOUS SYSTEM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ERYTHROPOIETIN; HUMANS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 45249120614     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720208784310231     Document Type: Review

References (338)

1. Anagnostou, A, Lee, ES, Kessimian, N, Levinson, R, Steiner, M. (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87: 5978-82.
2. Anagnostou, A, Liu, Z, Steiner, M, Chin, K, Lee, ES, Kessimian, N, Noguchi, CT. (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91: 3974-8.
3. Anitha, M, Gondha, C, Sutliff, R, Parsadanian, A, Mwangi, S, Sitaraman, SV, Srinivasan, S. (2006) GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest 116: 344-56.
4. Anjaneyulu, M, Berent-Spillson, A, Russell, JW. (2008) Metabotropic glutamate receptors (mGluRs) and diabetic neuropathy. Curr Drug Targets 9: 85-93.
5. Arcasoy, MO. (2008) The non-haematopoietic biological effects of erythropoietin. Br J Haematol 141: 14-31.
6. Asaumi, Y, Kagaya, Y, Takeda, M, Yamaguchi, N, Tada, H, Ito, K, Ohta, J, Shiroto, T, Shirato, K, Minegishi, N, Shimokawa, H. (2007) Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice. Circulation 115: 2022-32.
7. Ashley, RA, Dubuque, SH, Dvorak, B, Woodward, SS, Williams, SK, Kling, PJ. (2002) Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res 51: 472-8.
8. Assaraf, MI, Diaz, Z, Liberman, A, Miller, WH, Jr., Arvanitakis, Z, Li, Y, Bennett, DA, Schipper, HM. (2007) Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol 66: 389-98.
9. Avasarala, JR, Konduru, SS. (2005) Recombinant erythropoietin downregulates IL-6 and CXCR4 genes in TNF-alpha-treated primary cultures of human microvascular endothelial cells: implications for multiple sclerosis. J Mol Neurosci 25: 183-9.
10. Awad, N, Gagnon, M, Messier, C. (2004) The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26: 1044-80.
11. Bahlmann, FH, Song, R, Boehm, SM, Mengel, M, von Wasielewski, R, Lindschau, C, Kirsch, T, de Groot, K, Laudeley, R, Niemczyk, E, Guler, F, Menne, J, Haller, H, Fliser, D. (2004) Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 110: 1006-12.
12. Balaraman, Y, Limaye, AR, Levey, AI, Srinivasan, S. (2006) Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance. Cell Mol Life Sci 63: 1226-35.
13. Baoutina, A, Alexander, IE, Rasko, JE, Emslie, KR. (2007) Potential use of gene transfer in athletic performance enhancement. Mol Ther 15: 1751-66.
14. Bazan, JF. (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87: 6934-8.
15. Beeri, MS, Silverman, JM, Davis, KL, Marin, D, Grossman, HZ, Schmeidler, J, Purohit, DP, Perl, DP, Davidson, M, Mohs, RC, Haroutunian, V. (2005) Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci 60: 471-5.
16. Bierer, R, Peceny, MC, Hartenberger, CH, Ohls, RK. (2006) Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 118: e635-40.
17. Bittorf, T, Buchse, T, Sasse, T, Jaster, R, Brock, J. (2001) Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance. Cell Signal 13: 673-81.
18. Bittorf, T, Sasse, T, Wright, M, Jaster, R, Otte, L, Schneider-Mergener, J, Brock, J. (2000) cDNA cloning and functional analysis of a truncated STAT5a protein from autonomously growing FDCP-1 cells. Cell Signal 12: 721-30.
19. Bornemann, KD, Wiederhold, KH, Pauli, C, Ermini, F, Stalder, M, Schnell, L, Sommer, B, Jucker, M, Staufenbiel, M. (2001) Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol 158: 63-73.
20. Broudy, VC, Lin, N, Brice, M, Nakamoto, B, Papayannopoulou, T. (1991) Erythropoietin receptor characteristics on primary human erythroid cells. Blood 77: 2583-90.
21. Bullard, AJ, Govewalla, P, Yellon, DM. (2005) Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol 100: 397-403.
22. Bunn, HF, Gu, J, Huang, LE, Park, JW, Zhu, H. (1998) Erythropoietin: a model system for studying oxygen-dependent gene regulation. J Exp Biol 201: 1197-201.
23. Burger, D, Lei, M, Geoghegan-Morphet, N, Lu, X, Xenocostas, A, Feng, Q. (2006) Erythropoietin protects cardiomyocytes from apoptosis via upregulation of endothelial nitric oxide synthase. Cardiovasc Res 72: 51-9.
24. Cardella, F. (2005) Insulin therapy during diabetic ketoacidosis in children. Acta Biomed 76(Suppl 3): 49-54.
25. Cariou, A, Claessens, YE, Pene, F, Marx, JS, Spaulding, C, Hababou, C, Casadevall, N, Mira, JP, Carli, P, Hermine, O. (2008) Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation 76: 397-404.
26. Ceelen, W, Boterberg, T, Smeets, P, Van Damme, N, Demetter, P, Zwaenepoel, O, Cesteleyn, L, Houtmeyers, P, Peeters, M, Pattyn, P. (2007) Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels. Br J Cancer 96: 692-700.
27. Ceriello, A, dello Russo, P, Amstad, P, Cerutti, P. (1996) High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 45: 471-7.
28. Charvet, C, Alberti, I, Luciano, F, Jacquel, A, Bernard, A, Auberger, P, Deckert, M. (2003) Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases. Oncogene 22: 4557-68.
29. Chen, C, Edelstein, LC, Gelinas, C. (2000) The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20: 2687-95.
30. Chen, S, Guttridge, DC, You, Z, Zhang, Z, Fribley, A, Mayo, MW, Kitajewski, J, Wang, CY. (2001) Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol 152: 87-96.
31. Cherian, L, Goodman, JC, Robertson, C. (2007) Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats. J Pharmacol Exp Ther 322: 789-94.
32. Chikuma, M, Masuda, S, Kobayashi, T, Nagao, M, Sasaki, R. (2000) Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am J Physiol Endocrinol Metab 279: E1242-8.
33. Chlopicki, S, Swies, J, Mogielnicki, A, Buczko, W, Bartus, M, Lomnicka, M, Adamus, J, Gebicki, J. (2007) 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br J Pharmacol 152: 230-9.
34. Chong, ZZ, Kang, J, Li, F, Maiese, K. (2005a) mGluRI Targets Microglial Activation and Selectively Prevents Neuronal Cell Engulfment Through Akt and Caspase Dependent Pathways. Curr Neurovasc Res 2: 197-211.
35. Chong, ZZ, Kang, JQ, Maiese, K. (2004a) Akt1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-x(L) and caspase 1, 3, and 9. Exp Cell Res 296: 196-207.
36. Chong, ZZ, Kang, JQ, Maiese, K. (2002a) Angiogenesis and plasticity: role of erythropoietin in vascular systems. J Hematother Stem Cell Res 11: 863-71.
37. Chong, ZZ, Kang, JQ, Maiese, K. (2003a) Apaf-1, Bcl-xL, Cytochrome c, and Caspase-9 Form the Critical Elements for Cerebral Vascular Protection by Erythropoietin. J Cereb Blood Flow Metab 23: 320-30.
38. Chong, ZZ, Kang, JQ, Maiese, K. (2003b) Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol 138: 1107-1118.
39. Chong, ZZ, Kang, JQ, Maiese, K. (2002b) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106: 2973-9.
40. Chong, ZZ, Kang, JQ, Maiese, K. (2003c) Erythropoietin: cytoprotection in vascular and neuronal cells. Curr Drug Targets Cardiovasc Haematol Disord 3: 141-54.
41. Chong, ZZ, Kang, JQ, Maiese, K. (2004b) Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. Antioxid Redox Signal 6: 277-87.
42. Chong, ZZ, Kang, JQ, Maiese, K. (2002c) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22: 503-14.
43. Chong, ZZ, Kang, JQ, Maiese, K. (2003d) Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways. Histol Histopathol 18: 173-89.
44. Chong, ZZ, Li, F, Maiese, K. (2005b) Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol Histopathol 20: 299-315.
45. Chong, ZZ, Li, F, Maiese, K. (2006a) Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3. Curr Neurovasc Res 3: 25-39.
46. Chong, ZZ, Li, F, Maiese, K. (2007a) Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell Signal 19: 1150-62.
47. Chong, ZZ, Li, F, Maiese, K. (2005c) Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better? Curr Neurovasc Res 2: 55-72.
48. Chong, ZZ, Li, F, Maiese, K. (2005d) Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2: 387-99.
49. Chong, ZZ, Li, F, Maiese, K. (2006b) Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, bim, and beta-catenin during oxidative stress. Curr Neurovasc Res 3: 107-17.
50. Chong, ZZ, Li, F, Maiese, K. (2005e) Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75: 207-46.
51. Chong, ZZ, Li, F, Maiese, K. (2005f) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Brain Res Rev 49: 1-21.
52. Chong, ZZ, Li, F, Maiese, K. (2007b) The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. Int J Mol Med 19: 263-72.
53. Chong, ZZ, Lin, SH, Kang, JQ, Maiese, K. (2003e) Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J Neurosci Res 71: 659-69.
54. Chong, ZZ, Lin, SH, Kang, JQ, Maiese, K. (2003f) The tyrosine phosphatase SHP2 modulates MAP kinase p38 and caspase 1 and 3 to foster neuronal survival. Cell Mol Neurobiol 23: 561-78.
55. Chong, ZZ, Lin, SH, Li, F, Maiese, K. (2005g) The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through Akt, Bad, PARP, and mitochondrial associated "anti-apoptotic" pathways. Curr Neurovasc Res 2: 271-85.
56. Chong, ZZ, Lin, SH, Maiese, K. (2002d) Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J Vasc Res 39: 131-47.
57. Chong, ZZ, Lin, SH, Maiese, K. (2004c) The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J Cereb Blood Flow Metab 24: 728-43.
58. Chong, ZZ, Maiese, K. (2007a) Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br J Pharmacol 150: 839-50.
59. Chong, ZZ, Maiese, K. (2004) Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histol Histopathol 19: 495-504.
60. Chong, ZZ, Maiese, K. (2007b) The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol 22: 1251-67.
61. Chong, ZZ, Shang, YC, Maiese, K. (2007c) Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr Neurovasc Res 4: 194-204.
62. Clark, KL, Halay, ED, Lai, E, Burley, SK. (1993) Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364: 412-20.
63. Cohen, SM, Cordeiro-Stone, M, Kaufman, DG. (2007) Early replication and the apoptotic pathway. J Cell Physiol 213: 434-9.
64. Combs, CK, Karlo, JC, Kao, SC, Landreth, GE. (2001) beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21: 1179-88.
65. Contaldo, C, Meier, C, Elsherbiny, A, Harder, Y, Trentz, O, Menger, MD, Wanner, GA. (2007) Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice. Am J Physiol Heart Circ Physiol 293: H274-83.
66. Corwin, HL, Gettinger, A, Fabian, TC, May, A, Pearl, RG, Heard, S, An, R, Bowers, PJ, Burton, P, Klausner, MA, Corwin, MJ. (2007) Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 357: 965-76.
67. D'Andrea, AD, Zon, LI. (1990) Erythropoietin receptor. Subunit structure and activation. J Clin Invest 86: 681-7.
68. Dabelea, D, Bell, RA, D'Agostino, RB, Jr., Imperatore, G, Johansen, JM, Linder, B, Liu, LL, Loots, B, Marcovina, S, Mayer-Davis, EJ, Pettitt, DJ, Waitzfelder, B. (2007) Incidence of diabetes in youth in the United States. JAMA 297: 2716-24.
69. Damen, JE, Wakao, H, Miyajima, A, Krosl, J, Humphries, RK, Cutler, RL, Krystal, G. (1995) Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J 14: 5557-68.
70. Daneman, D. (2006) Type 1 diabetes. Lancet 367: 847-58.
71. Davis, LE, Widness, JA, Brace, RA. (2003) Renal and placental secretion of erythropoietin during anemia or hypoxia in the ovine fetus. Am J Obstet Gynecol 189: 1764-70.
72. De Felice, FG, Velasco, PT, Lambert, MP, Viola, K, Fernandez, SJ, Ferreira, ST, Klein, WL. (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282: 11590-601.
73. Demers, EJ, McPherson, RJ, Juul, SE. (2005) Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 58: 297-301.
74. Di Lisa, F, Menabo, R, Canton, M, Barile, M, Bernardi, P. (2001) Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276: 2571-5.
75. Diamanti-Kandarakis, E, Konstantinopoulos, PA, Papailiou, J, Kandarakis, SA, Andreopoulos, A, Sykiotis, GP. (2005) Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era. Sports Med 35: 831-40.
76. Digicaylioglu, M, Garden, G, Timberlake, S, Fletcher, L, Lipton, SA. (2004) Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc Natl Acad Sci USA 101: 9855-60.
77. Dombroski, D, Balasubramanian, K, Schroit, AJ. (2000) Phosphatidylserine expression on cell surfaces promotes antibody- dependent aggregation and thrombosis in beta2-glycoprotein I-immune mice. J Autoimmun 14: 221-9.
78. Donahoe, SM, Stewart, GC, McCabe, CH, Mohanavelu, S, Murphy, SA, Cannon, CP, Antman, EM. (2007) Diabetes and mortality following acute coronary syndromes. JAMA 298: 765-75.
79. Doolittle, ND, Peereboom, DM, Christoforidis, GA, Hall, WA, Palmieri, D, Brock, PR, Campbell, KC, Dickey, DT, Muldoon, LL, O'Neill, BP, Peterson, DR, Pollock, B, Soussain, C, Smith, Q, Tyson, RM, Neuwelt, EA. (2007) Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting. J Neurooncol 81: 81-91.
80. Duarte, AI, Proenca, T, Oliveira, CR, Santos, MS, Rego, AC. (2006) Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes 55: 2863-70.
81. Dube, S, Fisher, JW, Powell, JS. (1988) Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem 263: 17516-21.
82. Dzietko, M, Felderhoff-Mueser, U, Sifringer, M, Krutz, B, Bittigau, P, Thor, F, Heumann, R, Buhrer, C, Ikonomidou, C, Hansen, HH. (2004) Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 15: 177-87.
83. Earnshaw, WC, Martins, LM, Kaufmann, SH. (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424.
84. Eliopoulos, N, Gagnon, RF, Francois, M, Galipeau, J. (2006) Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. J Am Soc Nephrol 17: 1576-84.
85. Engels, IH, Stepczynska, A, Stroh, C, Lauber, K, Berg, C, Schwenzer, R, Wajant, H, Janicke, RU, Porter, AG, Belka, C, Gregor, M, Schulze-Osthoff, K, Wesselborg, S. (2000) Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 19: 4563-73.
86. Esposito, G, De Filippis, D, Maiuri, MC, De Stefano, D, Carnuccio, R, Iuvone, T. (2006) Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett 399: 91-5.
87. Eto, N, Wada, T, Inagi, R, Takano, H, Shimizu, A, Kato, H, Kurihara, H, Kawachi, H, Shankland, SJ, Fujita, T, Nangaku, M. (2007) Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. Kidney Int 72: 455-63.
88. Feng, Y, Paul, IA, LeBlanc, MH. (2006) Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat. Brain Res Bull 69: 117-22.
89. Fenjves, ES, Ochoa, MS, Cabrera, O, Mendez, AJ, Kenyon, NS, Inverardi, L, Ricordi, C. (2003) Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. Transplantation 75: 1356-60.
90. Ferrario, M, Massa, M, Rosti, V, Campanelli, R, Ferlini, M, Marinoni, B, De Ferrari, GM, Meli, V, De Amici, M, Repetto, A, Verri, A, Bramucci, E, Tavazzi, L. (2007) Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction. Eur Heart J 28: 1805-13.
91. Ferri, C, Giuggioli, D, Sebastiani, M, Colaci, M. (2007) Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin. Clin Exp Dermatol 32: 287-90.
92. Fisher, JW. (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 228: 1-14.
93. Fliser, D, Haller, H. (2007) Erythropoietin and treatment of non-anemic conditions - cardiovascular protection. Semin Hematol 44: 212-7.
94. Foller, M, Kasinathan, RS, Koka, S, Huber, SM, Schuler, B, Vogel, J, Gassmann, M, Lang, F. (2007) Enhanced susceptibility to suicidal death of erythrocytes from transgenic mice overexpressing erythropoietin. Am J Physiol Regul Integr Comp Physiol 293: R1127-34.
95. Frietsch, T, Maurer, MH, Vogel, J, Gassmann, M, Kuschinsky, W, Waschke, KF. (2007) Reduced cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin overexpressing transgenic mice with excessive erythrocytosis. J Cereb Blood Flow Metab 27: 469-76.
96. Fu, Q, Van Eyk, JE. (2006) Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev Proteomics 3: 237-49.
97. Gao, E, Boucher, M, Chuprun, JK, Zhou, RH, Eckhart, AD, Koch, WJ. (2007) Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart. Am J Physiol Heart Circ Physiol 293: H60-8.
98. Genc, S, Koroglu, TF, Genc, K. (2004) Erythropoietin as a novel neuroprotectant. Restor Neurol Neurosci 22: 105-19.
99. Gerozissis, K. (2003) Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 23: 1-25.
100. Giardino, I, Edelstein, D, Brownlee, M. (1996) BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 97: 1422-8.
101. Gleissner, CA, Klingenberg, R, Staritz, P, Koch, A, Ehlermann, P, Wiggenhauser, A, Dengler, TJ. (2006) Role of erythropoietin in anemia after heart transplantation. Int J Cardiol 112: 341-7.
102. Goldberg, N, Lundin, AP, Delano, B, Friedman, EA, Stein, RA. (1992) Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin. Am Heart J 124: 424-7.
103. Gonzalez, FF, McQuillen, P, Mu, D, Chang, Y, Wendland, M, Vexler, Z, Ferriero, DM. (2007) Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 29: 321-30.
104. Grant, SF, Thorleifsson, G, Reynisdottir, I, Benediktsson, R, Manolescu, A, Sainz, J, Helgason, A, Stefansson, H, Emilsson, V, Helgadottir, A, Styrkarsdottir, U, Magnusson, KP, Walters, GB, Palsdottir, E, Jonsdottir, T, Gudmundsdottir, T, Gylfason, A, Saemundsdottir, J, Wilensky, RL, Reilly, MP, Rader, DJ, Bagger, Y, Christiansen, C, Gudnason, V, Sigurdsson, G, Thorsteinsdottir, U, Gulcher, JR, Kong, A, Stefansson, K. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-3.
105. Grimm, C, Wenzel, A, Groszer, M, Mayser, H, Seeliger, M, Samardzija, M, Bauer, C, Gassmann, M, Reme, CE. (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8: 718-24.
106. Guo, G, Bhat, NR. (2006) Hypoxia/reoxygenation differentially modulates NF-kappaB activation and iNOS expression in astrocytes and microglia. Antioxid Redox Signal 8: 911-8.
107. Guo, YF, Xiong, DH, Shen, H, Zhao, LJ, Xiao, P, Guo, Y, Wang, W, Yang, TL, Recker, RR, Deng, HW. (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 43: 798-803.
108. Hara, N, Yamada, K, Shibata, T, Osago, H, Hashimoto, T, Tsuchiya, M. (2007) Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J Biol Chem 282: 24574-82.
109. Harris, SE, Fox, H, Wright, AF, Hayward, C, Starr, JM, Whalley, LJ, Deary, IJ. (2007) A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. BMC Genet 8: 43.
110. Hassan, K, Gross, B, Simri, W, Rubinchik, I, Cohen, H, Jacobi, J, Shasha, SM, Kristal, B. (2004) The presence of erythropoietin receptors in the human peripheral nervous system. Clin Nephrol 61: 127-9.
111. Hayden, MS, Ghosh, S. (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-224.
112. Heeschen, C, Aicher, A, Lehmann, R, Fichtlscherer, S, Vasa, M, Urbich, C, Mildner-Rihm, C, Martin, H, Zeiher, AM, Dimmeler, S. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-6.
113. Heidbreder, M, Frohlich, F, Johren, O, Dendorfer, A, Qadri, F, Dominiak, P. (2003) Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J 17: 1541-3.
114. Henke, M, Laszig, R, Rube, C, Schafer, U, Haase, KD, Schilcher, B, Mose, S, Beer, KT, Burger, U, Dougherty, C, Frommhold, H. (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362: 1255-60.
115. Henke, M, Mattern, D, Pepe, M, Bezay, C, Weissenberger, C, Werner, M, Pajonk, F. (2006) Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol 24: 4708-13.
116. Henry, DH, Bowers, P, Romano, MT, Provenzano, R. (2004) Epoetin alfa. Clinical evolution of a pleiotropic cytokine. Arch Intern Med 164: 262-76.
117. Henry, MK, Lynch, JT, Eapen, AK, Quelle, FW. (2001) DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. Blood 98: 834-41.
118. Hoffman, EC, Reyes, H, Chu, FF, Sander, F, Conley, LH, Brooks, BA, Hankinson, O. (1991) Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252: 954-8.
119. Hofmann, K, Bucher, P, Tschopp, J. (1997) The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci 22: 155-6.
120. Howlett, KF, Sakamoto, K, Yu, H, Goodyear, LJ, Hargreaves, M. (2006) Insulin-stimulated insulin receptor substrate-2-associated phosphatidylinositol 3-kinase activity is enhanced in human skeletal muscle after exercise. Metabolism 55: 1046-52.
121. Huang, LE, Gu, J, Schau, M, Bunn, HF. (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2- dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95: 7987-92.
122. Ieraci, A, Herrera, DG. (2006) Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med 3: e101.
123. Ihara, Y, Toyokuni, S, Uchida, K, Odaka, H, Tanaka, T, Ikeda, H, Hiai, H, Seino, Y, Yamada, Y. (1999) Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-32.
124. Ikeda, E. (2005) Cellular response to tissue hypoxia and its involvement in disease progression. Pathol Int 55: 603-10.
125. Imai, N, Kawamura, A, Higuchi, M, Oh-eda, M, Orita, T, Kawaguchi, T, Ochi, N. (1990) Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin. J Biochem (Tokyo) 107: 352-9.
126. Ito, N, Bartunek, J, Spitzer, KW, Lorell, BH. (1997) Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation 95: 2303-11.
127. Jacobs, K, Shoemaker, C, Rudersdorf, R, Neill, SD, Kaufman, RJ, Mufson, A, Seehra, J, Jones, SS, Hewick, R, Fritsch, EF, Kawakita, M, Shimizu, T, Miyake, T. (1985) Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313: 806-10.
128. Jacobsen, EA, Ananieva, O, Brown, ML, Chang, Y. (2006) Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene. J Immunol 176: 6831-8.
129. Jacobson, AM, Musen, G, Ryan, CM, Silvers, N, Cleary, P, Waberski, B, Burwood, A, Weinger, K, Bayless, M, Dahms, W, Harth, J. (2007) Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356: 1842-52.
130. Jaquet, K, Krause, K, Tawakol-Khodai, M, Geidel, S, Kuck, KH. (2002) Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 64: 326-33.
131. Jessel, R, Haertel, S, Socaciu, C, Tykhonova, S, Diehl, HA. (2002) Kinetics of apoptotic markers in exogeneously induced apoptosis of EL4 cells. J Cell Mol Med 6: 82-92.
132. Jin, C, Marsden, I, Chen, X, Liao, X. (1998) Sequence specific collective motions in a winged helix DNA binding domain detected by 15N relaxation NMR. Biochemistry 37: 6179-87.
133. Kaiser, K, Texier, A, Ferrandiz, J, Buguet, A, Meiller, A, Latour, C, Peyron, F, Cespuglio, R, Picot, S. (2006) Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J Infect Dis 193: 987-95.
134. Kanbay, M, Akcay, A, Delibasi, T, Uz, B, Kaya, A, Koca, C, Turgut, F, Bavbek, N, Uz, E, Duranay, M, Yigitoglu, R. (2007) Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure. Adv Ther 24: 346-52.
135. Kang, JQ, Chong, ZZ, Maiese, K. (2003a) Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity. J Neurosci Res 74: 37-51.
136. Kang, JQ, Chong, ZZ, Maiese, K. (2003b) Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol Pharmacol 64: 557-69.
137. Kaptanoglu, E, Solaroglu, I, Okutan, O, Surucu, HS, Akbiyik, F, Beskonakli, E. (2004) Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 27: 113-20.
138. Karunakaran, S, Diwakar, L, Saeed, U, Agarwal, V, Ramakrishnan, S, Iyengar, S, Ravindranath, V. (2007) Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. FASEB J 21: 2226-36.
139. Kawakami, M, Sekiguchi, M, Sato, K, Kozaki, S, Takahashi, M. (2001) Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 276: 39469-75.
140. Keogh, CL, Yu, SP, Wei, L. (2007) The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J Pharmacol Exp Ther 322: 521-8.
141. Kim, KH, Oudit, GY, Backx, PH. (2008) Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. J Pharmacol Exp Ther 324: 160-9.
142. King, VR, Averill, SA, Hewazy, D, Priestley, JV, Torup, L, Michael-Titus, AT. (2007) Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci 26: 90-100.
143. Kokhaei, P, Abdalla, AO, Hansson, L, Mikaelsson, E, Kubbies, M, Haselbeck, A, Jernberg-Wiklund, H, Mellstedt, H, Osterborg, A. (2007) Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies. Clin Cancer Res 13: 3536-44.
144. Koshimura, K, Murakami, Y, Sohmiya, M, Tanaka, J, Kato, Y. (1999) Effects of erythropoietin on neuronal activity. J Neurochem 72: 2565-72.
145. Krantz, SB. (1991) Erythropoietin. Blood 77: 419-34.
146. Kratzsch, J, Knerr, I, Galler, A, Kapellen, T, Raile, K, Korner, A, Thiery, J, Dotsch, J, Kiess, W. (2006) Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur J Endocrinol 155: 609-14.
147. Laakso, M. (2001) Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med 249: 225-35.
148. Lacombe, C, Da Silva, JL, Bruneval, P, Casadevall, N, Camilleri, JP, Bariety, J, Tambourin, P, Varet, B. (1991) Erythropoietin: sites of synthesis and regulation of secretion. Am J Kidney Dis 18: 14-9.
149. Lai, SY, Grandis, JR. (2006) Understanding the presence and function of erythropoietin receptors on cancer cells. J Clin Oncol 24: 4675-6.
150. Larson, ET, Eilers, B, Menon, S, Reiter, D, Ortmann, A, Young, MJ, Lawrence, CM. (2007) A winged-helix protein from Sulfolobus turreted icosahedral virus points toward stabilizing disulfide bonds in the intracellular proteins of a hyperthermophilic virus. Virology 368: 249-61.
151. Lehman, DM, Hunt, KJ, Leach, RJ, Hamlington, J, Arya, R, Abboud, HE, Duggirala, R, Blangero, J, Goring, HH, Stern, MP. (2007) Haplotypes of Transcription Factor 7-Like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 56: 389-93.
152. Lehtinen, MK, Yuan, Z, Boag, PR, Yang, Y, Villen, J, Becker, EB, DiBacco, S, de la Iglesia, N, Gygi, S, Blackwell, TK, Bonni, A. (2006) A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125: 987-1001.
153. Leuner, K, Hauptmann, S, Abdel-Kader, R, Scherping, I, Keil, U, Strosznajder, JB, Eckert, A, Muller, WE. (2007) Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal 9: 1659-75.
154. Leyland-Jones, B, Semiglazov, V, Pawlicki, M, Pienkowski, T, Tjulandin, S, Manikhas, G, Makhson, A, Roth, A, Dodwell, D, Baselga, J, Biakhov, M, Valuckas, K, Voznyi, E, Liu, X, Vercammen, E. (2005) Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 23: 5960-72.
155. Leytin, V, Allen, DJ, Mykhaylov, S, Lyubimov, E, Freedman, J. (2006) Thrombin-triggered platelet apoptosis. J Thromb Haemost 4: 2656-63.
156. Li, F, Chong, ZZ, Maiese, K. (2006a) Cell life versus cell longevity: the mysteries surrounding the nad(+) precursor nicotinamide. Curr Med Chem 13: 883-95.
157. Li, F, Chong, ZZ, Maiese, K. (2004a) Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. Neurosignals 13: 265-89.
158. Li, F, Chong, ZZ, Maiese, K. (2006b) Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. Curr Neurovasc Res 3: 187-201.
159. Li, F, Chong, ZZ, Maiese, K. (2004b) Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide. Front Biosci 9: 2500-2520.
160. Li, F, Chong, ZZ, Maiese, K. (2005) Vital elements of the wnt-frizzled signaling pathway in the nervous system. Curr Neurovasc Res 2: 331-40.
161. Li, F, Chong, ZZ, Maiese, K. (2006c) Winding through the WNT pathway during cellular development and demise. Histol Histopathol 21: 103-24.
162. Li, P, Nijhawan, D, Budihardjo, I, Srinivasula, SM, Ahmad, M, Alnemri, ES, Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-89.
163. Li, Y, Lu, Z, Keogh, CL, Yu, SP, Wei, L. (2007a) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 27: 1043-54.
164. Li, Y, Wang, Z, Kong, D, Murthy, S, Dou, QP, Sheng, S, Reddy, GP, Sarkar, FH. (2007b) Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 282: 21542-50.
165. Lin, CL, Wang, JY, Huang, YT, Kuo, YH, Surendran, K, Wang, FS. (2006) Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol 17: 2812-20.
166. Lin, FK, Suggs, S, Lin, CH, Browne, JK, Smalling, R, Egrie, JC, Chen, KK, Fox, GM, Martin, F, Stabinsky, Z, Badrawi, SM, Lai, P-H, Goldwasser, E. (1985) Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 82: 7580-4.
167. Lin, SH, Maiese, K. (2001) The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. J Cereb Blood Flow Metab 21: 262-75.
168. Lin, SH, Vincent, A, Shaw, T, Maynard, KI, Maiese, K. (2000) Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J Cereb Blood Flow Metab 20: 1380-91.
169. Ling, PR, Mueller, C, Smith, RJ, Bistrian, BR. (2003) Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism 52: 868-74.
170. Lipton, SA. (2007) Pathologically activated therapeutics for neuroprotection. Nat Rev Neurosci 8: 803-8.
171. Liu, C, Shen, K, Liu, Z, Noguchi, CT. (1997) Regulated human erythropoietin receptor expression in mouse brain. J Biol Chem 272: 32395-400.
172. Liu, R, Suzuki, A, Guo, Z, Mizuno, Y, Urabe, T. (2006) Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro. J Neurochem 96: 1101-10.
173. Liu, ZY, Chin, K, Noguchi, CT. (1994) Tissue specific expression of human erythropoietin receptor in transgenic mice. Dev Biol 166: 159-69.
174. Luchsinger, JA, Tang, MX, Stern, Y, Shea, S, Mayeux, R. (2001) Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154: 635-41.
175. Lykissas, MG, Korompilias, AV, Vekris, MD, Mitsionis, GI, Sakellariou, E, Beris, AE. (2007) The role of erythropoietin in central and peripheral nerve injury. Clin Neurol Neurosurg 109: 639-44.
176. Maiese, K. (2008a) Diabetic stress: new triumphs and challenges to maintain vascular longevity. Expert Rev Cardiovasc Ther 6: 281-4.
177. Maiese, K. (2001) The dynamics of cellular injury: transformation into neuronal and vascular protection. Histol Histopathol 16: 633-44.
178. Maiese, K. (2008b) Triple play: Promoting neurovascular longevity with nicotinamide, Wnt, and erythropoietin in diabetes mellitus. Biomed Pharmacother 10.1016/j.biopha.2008.01.009:
179. Maiese, K, Ahmad, I, TenBroeke, M, Gallant, J. (1999) Metabotropic glutamate receptor subtypes independently modulate neuronal intracellular calcium. J Neurosci Res 55: 472-485.
180. Maiese, K, Boccone, L. (1995) Neuroprotection by peptide growth factors against anoxia and nitric oxide toxicity requires modulation of protein kinase C. J Cereb Blood Flow Metab 15: 440-9.
181. Maiese, K, Chong, ZZ. (2004) Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. Restor Neurol Neurosci 22: 87-104.
182. Maiese, K, Chong, ZZ. (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol Sci 24: 228-32.
183. Maiese, K, Chong, ZZ, Kang, J. (2003) Transformation into treatment: Novel therapeutics that begin within the cell. In: Neuronal and Vascular Plasticity: Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery. Maiese, K, Ed., Kluwer Academic Publishers: Norwell, MA 1-26.
184. Maiese, K, Chong, ZZ, Li, F. (2005a) Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. Curr Neurovasc Res 2: 425-46.
185. Maiese, K, Chong, ZZ, Li, F, Shang, YC. (2008a) Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies. Prog Neurobiol 10.1016/j.pneurobio.2008.02.002:
186. Maiese, K, Chong, ZZ, Shang, YC. (2007a) Mechanisitic insights into diabetes mellitus and oxidative stress. Curr Med Chem 14: 1689-1699.
187. Maiese, K, Chong, ZZ and Shang, YC. (2008b) OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol Med 10.1016/j.molmed.2008.03.002.
188. Maiese, K, Chong, ZZ, Shang, YC. (2008c) Raves and risks for erythropoietin. Cytokine Growth Factor Rev 19: 145-155.
189. Maiese, K, Chong, ZZ, Shang, YC. (2007b) "Sly as a FOXO": New paths with Forkhead signaling in the brain. Curr Neurovasc Res 4: 295-302.
190. Maiese, K, Li, F, Chong, ZZ. (2005b) Erythropoietin and cancer. JAMA 293: 1858-1859.
191. Maiese, K, Li, F, Chong, ZZ. (2004) Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol Sci 25: 577-583.
192. Maiese, K, Li, F, Chong, ZZ. (2005c) New avenues of exploration for erythropoietin. JAMA 293: 90-5.
193. Maiese, K, Li, F, Chong, ZZ, Shang, Y. (2008d) The Wnt signaling pathway: Aging gracefully as a protectionist? Pharmacol Ther doi:10.1016/j. pharmthera.2008.01.004.
194. Maiese, K, Morhan, SD, Chong, ZZ. (2007c) Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res 4: 63-71.
195. Maiese, K, TenBroeke, M, Kue, I. (1997) Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide. J Neurochem 68: 710-4.
196. Maiese, K, Vincent, A, Lin, SH, Shaw, T. (2000) Group I and Group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection. J Neurosci Res 62: 257-272.
197. Maiese, K, Vincent, AM. (2000a) Critical temporal modulation of neuronal programmed cell injury. Cell Mol Neurobiol 20: 383-400.
198. Maiese, K, Vincent, AM. (2000b) Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death. J Neurosci Res 59: 568-80.
199. Maiorana, A, O'Driscoll, G, Goodman, C, Taylor, R, Green, D. (2002) Combined aerobic and resistance exercise improves glycemic control and fitness in type 2 diabetes. Diabetes Res Clin Pract 56: 115-23.
200. Mallat, M, Marin-Teva, JL, Cheret, C. (2005) Phagocytosis in the developing CNS: more than clearing the corpses. Curr Opin Neurobiol 15: 101-7.
201. Mancini, DM, Katz, SD, Lang, CC, LaManca, J, Hudaihed, A, Androne, AS. (2003) Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107: 294-9.
202. Mari, C, Karabiyikoglu, M, Goris, ML, Tait, JF, Yenari, MA, Blankenberg, FG. (2004) Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V. Eur J Nucl Med Mol Imaging 31: 733-9.
203. Marti, HH, Wenger, RH, Rivas, LA, Straumann, U, Digicaylioglu, M, Henn, V, Yonekawa, Y, Bauer, C, Gassmann, M. (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8: 666-76.
204. Martin, D, Salinas, M, Lopez-Valdaliso, R, Serrano, E, Recuero, M, Cuadrado, A. (2001) Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells. J Neurochem 78: 1000-8.
205. Martinez-Estrada, OM, Rodriguez-Millan, E, Gonzalez-De Vicente, E, Reina, M, Vilaro, S, Fabre, M. (2003) Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18: 2538-44.
206. Mason-Garcia, M, Beckman, BS, Brookins, JW, Powell, JS, Lanham, W, Blaisdell, S, Keay, L, Li, SC, Fisher, JW. (1990) Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietin. Kidney Int 38: 969-75.
207. Masuda, S, Kobayashi, T, Chikuma, M, Nagao, M, Sasaki, R. (2000) The oviduct produces erythropoietin in an estrogen- and oxygen- dependent manner. Am J Physiol Endocrinol Metab 278: E1038-44.
208. Matsuzaki, H, Tamatani, M, Mitsuda, N, Namikawa, K, Kiyama, H, Miyake, S, Tohyama, M. (1999) Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J Neurochem 73: 2037-46.
209. Maxwell, PH, Wiesener, MS, Chang, GW, Clifford, SC, Vaux, EC, Cockman, ME, Wykoff, CC, Pugh, CW, Maher, ER, Ratcliffe, PJ. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-5.
210. McLeod, M, Hong, M, Mukhida, K, Sadi, D, Ulalia, R, Mendez, I. (2006) Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. Eur J Neurosci 24: 361-70.
211. Meloni, BP, Tilbrook, PA, Boulos, S, Arthur, PG, Knuckey, NW. (2006) Erythropoietin preconditioning in neuronal cultures: signaling, protection from in vitro ischemia, and proteomic analysis. J Neurosci Res 83: 584-93.
212. Memisogullari, R, Bakan, E. (2004) Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. J Diabetes Complications 18: 193-7.
213. Menon, MP, Fang, J, Wojchowski, DM. (2006a) Core erythropoietin receptor signals for late erythroblast development. Blood 107: 2662-72.
214. Menon, MP, Karur, V, Bogacheva, O, Bogachev, O, Cuetara, B, Wojchowski, DM. (2006b) Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. J Clin Invest 116: 683-94.
215. Mikati, MA, Hokayem, JA, Sabban, ME. (2007) Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at p10. Epilepsia 48: 175-81.
216. Miki, T, Miura, T, Yano, T, Takahashi, A, Sakamoto, J, Tanno, M, Kobayashi, H, Ikeda, Y, Nishihara, M, Naitoh, K, Ohori, K, Shimamoto, K. (2006) Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling. J Pharmacol Exp Ther 317: 68-75.
217. Mocini, D, Leone, T, Tubaro, M, Santini, M, Penco, M. (2007) Structure, production and function of erythropoietin: implications for therapeutical use in cardiovascular disease. Curr Med Chem 14: 2278-87.
218. Mojiminiyi, OA, Abdella, NA, Zaki, MY, El Gebely, SA, Mohamedi, HM, Aldhahi, WA. (2006) Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus. Diabet Med 23: 839-44.
219. Monnier, L, Mas, E, Ginet, C, Michel, F, Villon, L, Cristol, JP, Colette, C. (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295: 1681-7.
220. Montero, M, Poulsen, FR, Noraberg, J, Kirkeby, A, van Beek, J, Leist, M, Zimmer, J. (2007) Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures. Exp Neurol 204: 106-17.
221. Moon, C, Krawczyk, M, Ahn, D, Ahmet, I, Paik, D, Lakatta, EG, Talan, MI. (2003) Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 100: 11612-7.
222. Moon, C, Krawczyk, M, Paik, D, Coleman, T, Brines, M, Juhaszova, M, Sollott, SJ, Lakatta, EG, Talan, MI. (2006) Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. J Pharmacol Exp Ther 316: 999-1005.
223. Mujais, SK, Beru, N, Pullman, TN, Goldwasser, E. (1999) Erythropoietin is produced by tubular cells of the rat kidney. Cell Biochem Biophys 30: 153-66.
224. Mulcahy, L. (2001) The erythropoietin receptor. Semin Oncol 28: 19-23.
225. Muller, FL, Lustgarten, MS, Jang, Y, Richardson, A, Van Remmen, H. (2007) Trends in oxidative aging theories. Free Radic Biol Med 43: 477-503.
226. Mussmann, R, Geese, M, Harder, F, Kegel, S, Andag, U, Lomow, A, Burk, U, Onichtchouk, D, Dohrmann, C, Austen, M. (2007) Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. J Biol Chem 282: 12030-7.
227. Nadam, J, Navarro, F, Sanchez, P, Moulin, C, Georges, B, Laglaine, A, Pequignot, JM, Morales, A, Ryvlin, P, Bezin, L. (2007) Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol Dis 25: 412-26.
228. Nagai, A, Nakagawa, E, Choi, HB, Hatori, K, Kobayashi, S, Kim, SU. (2001) Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 60: 386-92.
229. Nagata, Y, Takahashi, N, Davis, RJ, Todokoro, K. (1998) Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92: 1859-69.
230. Nakagawa, T, Zhu, H, Morishima, N, Li, E, Xu, J, Yankner, BA, Yuan, J. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98-103.
231. Nakata, S, Matsumura, I, Tanaka, H, Ezoe, S, Satoh, Y, Ishikawa, J, Era, T, Kanakura, Y. (2004) NF-kappaB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. J Biol Chem 279: 55578-86.
232. Namikawa, K, Honma, M, Abe, K, Takeda, M, Mansur, K, Obata, T, Miwa, A, Okado, H, Kiyama, H. (2000) Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci 20: 2875-86.
233. Namiuchi, S, Kagaya, Y, Ohta, J, Shiba, N, Sugi, M, Oikawa, M, Kunii, H, Yamao, H, Komatsu, N, Yui, M, Tada, H, Sakuma, M, Watanabe, J, Ichihara, T, Shirato, K. (2005) High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol 45: 1406-12.
234. Newsholme, P, Haber, EP, Hirabara, SM, Rebelato, EL, Procopio, J, Morgan, D, Oliveira-Emilio, HC, Carpinelli, AR, Curi, R. (2007) Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 583: 9-24.
235. Ning, S, Hartley, C, Molineux, G, Knox, SJ. (2005) Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemia. Cancer Res 65: 284-90.
236. Nurmi, A, Goldsteins, G, Narvainen, J, Pihlaja, R, Ahtoniemi, T, Grohn, O, Koistinaho, J. (2006) Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxiaischemia. Free Radic Biol Med 40: 1776-84.
237. Obara, N, Imagawa, S, Nakano, Y, Suzuki, N, Yamamoto, M, Nagasawa, T. (2003) Suppression of erythropoietin gene expression by cadmium depends on inhibition of HIF-1, not stimulation of GATA-2. Arch Toxicol 77: 267-73.
238. Ogilvie, M, Yu, X, Nicolas-Metral, V, Pulido, SM, Liu, C, Ruegg, UT, Noguchi, CT. (2000) Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 275: 39754-61.
239. Okouchi, M, Ekshyyan, O, Maracine, M, Aw, TY. (2007) Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal 9: 1059-96.
240. Okutan, O, Solaroglu, I, Beskonakli, E, Taskin, Y. (2007) Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats. J Clin Neurosci 14: 364-8.
241. Olea, FD, Vera Janavel, G, De Lorenzi, A, Cuniberti, L, Yannarelli, G, Cabeza Meckert, P, Cearras, M, Laguens, R, Crottogini, A. (2006) High-dose erythropoietin has no long-term protective effects in sheep with reperfused myocardial infarction. J Cardiovasc Pharmacol 47: 736-41.
242. Olsen, NV. (2003) Central nervous system frontiers for the use of erythropoietin. Clin Infect Dis 37(Suppl 4): S323-30.
243. Orive, G, De Castro, M, Ponce, S, Hernandez, RM, Gascon, AR, Bosch, M, Alberch, J, Pedraz, JL. (2005) Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol Ther 12: 283-9.
244. Palazzuoli, A, Silverberg, D, Iovine, F, Capobianco, S, Giannotti, G, Calabro, A, Campagna, SM, Nuti, R. (2006) Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 152: 1096. e9-15.
245. Parsa, CJ, Kim, J, Riel, RU, Pascal, LS, Thompson, RB, Petrofski, JA, Matsumoto, A, Stamler, JS, Koch, WJ. (2004) Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 279: 20655-62.
246. Parsa, CJ, Matsumoto, A, Kim, J, Riel, RU, Pascal, LS, Walton, GB, Thompson, RB, Petrofski, JA, Annex, BH, Stamler, JS, Koch, WJ. (2003) A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112: 999-1007.
247. Pearl, R. (1928) The rate of living. University of London Press, London
248. Ponce, S, Orive, G, Hernandez, RM, Gascon, AR, Canals, JM, Munoz, MT, Pedraz, JL. (2006) In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. J Control Release 116: 28-34.
249. Pregi, N, Vittori, D, Perez, G, Leiros, CP, Nesse, A. (2006) Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells. Biochim Biophys Acta 1763: 238-46.
250. Qin, W, Peng, Y, Ksiezak-Reding, H, Ho, L, Stetka, B, Lovati, E, Pasinetti, GM. (2006) Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease. Mol Psychiatry 11: 172-81.
251. Rades, D, Golke, H, Schild, SE, Kilic, E. (2007) The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. Int J Radiat Oncol Biol Phys [Epub ahead of print].
252. Ravid, O, Shams, I, Ben Califa, N, Nevo, E, Avivi, A, Neumann, D. (2007) An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation. Proc Natl Acad Sci USA 104: 14360-5.
253. Reddy, MK, Vasir, JK, Hegde, GV, Joshi, SS, Labhasetwar, V. (2007) Erythropoietin induces excessive neointima formation: a study in a rat carotid artery model of vascular injury. J Cardiovasc Pharmacol Ther 12: 237-47.
254. Regulska, M, Leskiewicz, M, Budziszewska, B, Kutner, A, Jantas, D, Basta-Kaim, A, Kubera, M, Jaworska-Feil, L, Lason, W. (2007) Inhibitory effects of 1,25-dihydroxyvitamin D(3) and its low-calcemic analogues on staurosporine-induced apoptosis. Pharmacol Rep 59: 393-401.
255. Reich, NC. (2007) STAT dynamics. Cytokine Growth Factor Rev 18: 511-8.
256. Reinders, ME, Rabelink, TJ, Briscoe, DM. (2006) Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol 17: 932-42.
257. Roberts, E, Jr. and Chih, CP. (1997) The influence of age of pH regulation in hippocampal slices before, during, and after anoxia. J Cereb Blood Flow Metab 17: 560-6.
258. Rowe, MK, Wiest, C, Chuang, DM. (2007) GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder. Neurosci Biobehav Rev 31: 920-31.
259. Rytomaa, M, Lehmann, K, Downward, J. (2000) Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 19: 4461-8.
260. Sae-Ung, N, Matsushima, T, Choi, I, Abe, Y, Winichagoon, P, Fucharoen, S, Nawata, H, Muta, K. (2005) Role of NF-kappa B in regulation of apoptosis of erythroid progenitor cells. Eur J Haematol 74: 315-23.
261. Salinas, M, Diaz, R, Abraham, NG, Ruiz de Galarreta, CM, Cuadrado, A. (2003) Nerve growth factor protects against 6-hydroxydopamineinduced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem 278: 13898-904.
262. Sanz, O, Acarin, L, Gonzalez, B, Castellano, B. (2002) NF-kappaB and IkappaBalpha expression following traumatic brain injury to the immature rat brain. J Neurosci Res 67: 772-80.
263. Sasaki, Y, Sasaki, Y, Kanno, K, Hidaka, H. (1987) Disorganization by calcium antagonists of actin microfilament in aortic smooth muscle cells. Am J Physiol 253: C71-8.
264. Sathyanarayana, P, Menon, MP, Bogacheva, O, Bogachev, O, Niss, K, Kapelle, WS, Houde, E, Fang, J, Wojchowski, DM. (2007) Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. Blood 110: 509-18.
265. Schmeding, M, Neumann, UP, Boas-Knoop, S, Spinelli, A, Neuhaus, P. (2007) Erythropoietin reduces ischemia-reperfusion injury in the rat liver. Eur Surg Res 39: 189-97.
266. Schnaider Beeri, M, Goldbourt, U, Silverman, JM, Noy, S, Schmeidler, J, Ravona-Springer, R, Sverdlick, A, Davidson, M. (2004) Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 63: 1902-7.
267. Schumann, C, Triantafilou, K, Krueger, S, Hombach, V, Triantafilou, M, Becher, G, Lepper, PM. (2006) Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array. Mediators Inflamm 2006: 18061.
268. Scott, LJ, Bonnycastle, LL, Willer, CJ, Sprau, AG, Jackson, AU, Narisu, N, Duren, WL, Chines, PS, Stringham, HM, Erdos, MR, Valle, TT, Tuomilehto, J, Bergman, RN, Mohlke, KL, Collins, FS, Boehnke, M. (2006) Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55: 2649-53.
269. Segura, J, Pascual, JA, Gutierrez-Gallego, R. (2007) Procedures for monitoring recombinant erythropoietin and analogues in doping control. Anal Bioanal Chem 388: 1521-9.
270. Sharples, EJ, Patel, N, Brown, P, Stewart, K, Mota-Philipe, H, Sheaff, M, Kieswich, J, Allen, D, Harwood, S, Raftery, M, Thiemermann, C, Yaqoob, MM. (2004) Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15: 2115-24.
271. Sharples, EJ, Thiemermann, C, Yaqoob, MM. (2005) Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Nat Clin Pract Nephrol 1: 87-97.
272. Sharples, EJ, Yaqoob, MM. (2006) Erythropoietin in experimental acute renal failure. Nephron Exp Nephrol 104: e83-8.
273. Sigounas, G, Sallah, S, Sigounas, VY. (2004) Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model. Cancer Lett 214: 171-9.
274. Silverberg, DS, Wexler, D, Iaina, A, Schwartz, D. (2006) The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 26: 296-306.
275. Silverberg, DS, Wexler, D, Sheps, D, Blum, M, Keren, G, Baruch, R, Schwartz, D, Yachnin, T, Steinbruch, S, Shapira, I, Laniado, S, Iaina, A. (2001) The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intrave nous iron: a randomized controlled study. J Am Coll Cardiol 37: 1775-80.
276. Singh, DK, Winocour, P, Farrington, K. (2008) Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol 4: 216-26.
277. Slevin, M, Kumar, P, Gaffney, J, Kumar, S, Krupinski, J. (2006) Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci (Lond) 111: 171-83.
278. Socolovsky, M, Fallon, AE, Wang, S, Brugnara, C, Lodish, HF. (1999) Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98: 181-91.
279. Socolovsky, M, Nam, H, Fleming, MD, Haase, VH, Brugnara, C, Lodish, HF. (2001) Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 98: 3261-73.
280. Spandou, E, Tsouchnikas, I, Karkavelas, G, Dounousi, E, Simeonidou, C, Guiba-Tziampiri, O, Tsakiris, D. (2006) Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 21: 330-6.
281. Speese, SD, Budnik, V. (2007) Wnts: up-and-coming at the synapse. Trends Neurosci 30: 268-75.
282. Stegh, AH, Barnhart, BC, Volkland, J, Algeciras-Schimnich, A, Ke, N, Reed, JC, Peter, ME. (2002) Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein. J Biol Chem 277: 4351-60.
283. Stolze, I, Berchner-Pfannschmidt, U, Freitag, P, Wotzlaw, C, Rossler, J, Frede, S, Acker, H, Fandrey, J. (2002) Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood 100: 2623-8.
284. Sun, XM, Cohen, GM. (1994) Mg(2+)-dependent cleavage of DNA into kilobase pair fragments is responsible for the initial degradation of DNA in apoptosis. J Biol Chem 269: 14857-60.
285. Symeonidis, A, Kouraklis-Symeonidis, A, Psiroyiannis, A, Leotsinidis, M, Kyriazopoulou, V, Vassilakos, P, Vagenakis, A, Zoumbos, N. (2006) Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus. Ann Hematol 85: 79-85.
286. Takahashi, H, Nakamura, S, Asano, K, Kinouchi, M, Ishida-Yamamoto, A, Iizuka, H. (1999) Fas antigen modulates ultraviolet B-induced apoptosis of SVHK cells: sequential activation of caspases 8, 3, and 1 in the apoptotic process. Exp Cell Res 249: 291-8.
287. Tamagno, E, Robino, G, Obbili, A, Bardini, P, Aragno, M, Parola, M, Danni, O. (2003) H2O2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp Neurol 180: 144-55.
288. Tanuma, N, Sakuma, H, Sasaki, A, Matsumoto, Y. (2006) Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol (Berl) 112: 195-204.
289. Teramo, K, Kari, MA, Eronen, M, Markkanen, H, Hiilesmaa, V. (2004) High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia 47: 1695-703.
290. Thomas, MC, Cooper, ME, Tsalamandris, C, MacIsaac, R, Jerums, G. (2005) Anemia with impaired erythropoietin response in diabetic patients. Arch Intern Med 165: 466-9.
291. Toma, C, Letts, DP, Tanabe, M, Gorcsan, J, 3rd and Counihan, PJ. (2007) Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion. J Mol Cell Cardiol 43: 130-6.
292. Torriglia, A, Chaudun, E, Courtois, Y, Counis, MF. (1997) On the use of Zn2+ to discriminate endonucleases activated during apoptosis. Biochimie 79: 435-8.
293. Toyoda, T, Itai, T, Arakawa, T, Aoki, KH, Yamaguchi, H. (2000) Stabilization of human recombinant erythropoietin through interactions with the highly branched N-glycans. J Biochem (Tokyo) 128: 731-7.
294. Tramontano, AF, Muniyappa, R, Black, AD, Blendea, MC, Cohen, I, Deng, L, Sowers, JR, Cutaia, MV, El-Sherif, N. (2003) Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 308: 990-4.
295. Troy, CM, Rabacchi, SA, Xu, Z, Maroney, AC, Connors, TJ, Shelanski, ML, Greene, LA. (2001) beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem 77: 157-64.
296. Tsai, JC, Song, BJ, Wu, L, Forbes, M. (2007) Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma. J Glaucoma 16: 567-71.
297. Tsuda, E, Goto, M, Murakami, A, Akai, K, Ueda, M, Kawanishi, G, Takahashi, N, Sasaki, R, Chiba, H, Ishihara, H, Mori, M, Tejima, S, Endo, S, Arata, Y. (1988) Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins. Biochemistry 27: 5646-54.
298. Tsuda, E, Kawanishi, G, Ueda, M, Masuda, S, Sasaki, R. (1990) The role of carbohydrate in recombinant human erythropoietin. Eur J Biochem 188: 405-11.
299. Uchida, E, Morimoto, K, Kawasaki, N, Izaki, Y, Abdu Said, A, Hayakawa, T. (1997) Effect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietin. Free Radic Res 27: 311-23.
300. Um, M, Gross, AW, Lodish, HF. (2007) A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal 19: 634-45.
301. Um, M, Lodish, HF. (2006) Antiapoptotic Effects of Erythropoietin in Differentiated Neuroblastoma SH-SY5Y Cells Require Activation of Both the STAT5 and AKT Signaling Pathways. J Biol Chem 281: 5648-56.
302. Vairano, M, Dello Russo, C, Pozzoli, G, Battaglia, A, Scambia, G, Tringali, G, Aloe-Spiriti, MA, Preziosi, P, Navarra, P. (2002) Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci 16: 584-92.
303. van der Meer, P, Lipsic, E, Henning, RH, de Boer, RA, Suurmeijer, AJ, van Veldhuisen, DJ, van Gilst, WH. (2004a) Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur J Heart Fail 6: 853-9.
304. van der Meer, P, Voors, AA, Lipsic, E, Smilde, TD, van Gilst, WH, van Veldhuisen, DJ. (2004b) Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 44: 63-7.
305. Vanags, DM, Porn-Ares, MI, Coppola, S, Burgess, DH, Orrenius, S. (1996) Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 271: 31075-85.
306. Verdaguer, E, Susana Gde, A, Clemens, A, Pallas, M, Camins, A. (2007) Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis. Biomed Pharmacother 61: 390-9.
307. Verdonck, O, Lahrech, H, Francony, G, Carle, O, Farion, R, Van de Looij, Y, Remy, C, Segebarth, C, Payen, JF. (2007) Erythropoietin protects from post-traumatic edema in the rat brain. J Cereb Blood Flow Metab 27: 1369-76.
308. Vincent, AM, Maiese, K. (1999a) Direct temporal analysis of apoptosis induction in living adherent neurons. J Histochem Cytochem 47: 661-72.
309. Vincent, AM, Maiese, K. (1999b) Nitric oxide induction of neuronal endonuclease activity in programmed cell death. Exp Cell Res 246: 290-300.
310. Vincent, AM, TenBroeke, M, Maiese, K. (1999a) Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuclease activity and intracellular pH. Exp Neurol 155: 79-94.
311. Vincent, AM, TenBroeke, M, Maiese, K. (1999b) Neuronal intracellular pH directly mediates nitric oxide-induced programmed cell death. J Neurobiol 40: 171-84.
312. Walshe, TE, D'Amore, PA. (2008) The role of hypoxia in vascular injury and repair. Annu Rev Pathol 3: 615-43.
313. Wang, FF, Kung, CK, Goldwasser, E. (1985) Some chemical properties of human erythropoietin. Endocrinology 116: 2286-92.
314. Wang, GL, Semenza, GL. (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-7.
315. Watowich, SS, Hilton, DJ, Lodish, HF. (1994) Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol Cell Biol 14: 3535-49.
316. Wei, L, Han, BH, Li, Y, Keogh, CL, Holtzman, DM, Yu, SP. (2006) Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 317: 109-16.
317. Westenbrink, BD, Lipsic, E, van der Meer, P, van der Harst, P, Oeseburg, H, Du Marchie Sarvaas, GJ, Koster, J, Voors, AA, van Veldhuisen, DJ, van Gilst, WH, Schoemaker, RG. (2007) Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 28: 2018-27.
318. Wild, S, Roglic, G, Green, A, Sicree, R, King, H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-53.
319. Wilks, AF, Harpur, AG, Kurban, RR, Ralph, SJ, Zurcher, G, Ziemiecki, A. (1991) Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 11: 2057-65.
320. Wilson, FH, Hariri, A, Farhi, A, Zhao, H, Petersen, KF, Toka, HR, Nelson-Williams, C, Raja, KM, Kashgarian, M, Shulman, GI, Scheinman, SJ, Lifton, RP. (2004) A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306: 1190-4.
321. Wright, WS, Longo, KA, Dolinsky, VW, Gerin, I, Kang, S, Bennett, CN, Chiang, SH, Prestwich, TC, Gress, C, Burant, CF, Susulic, VS, Macdougald, OA. (2007) Wnt10b Inhibits Obesity in ob/ob and Agouti Mice. Diabetes 56: 295-303.
322. Wu, H, Ren, B, Zhu, J, Dong, G, Xu, B, Wang, C, Zheng, X, Jing, H. (2006) Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats. Eur J Cardiothorac Surg 29: 902-7.
323. Wu, Y, Shang, Y, Sun, S, Liang, H, Liu, R. (2007a) Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis 12: 1365-75.
324. Wu, Y, Shang, Y, Sun, S, Liu, R. (2007b) Antioxidant effect of erythropoietin on 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells. Eur J Pharmacol 564: 47-56.
325. Xu, B, Dong, GH, Liu, H, Wang, YQ, Wu, HW, Jing, H. (2005) Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: a possible mechanism involves heat shock Protein 70 and attenuation of nuclear factor-kappaB. Ann Clin Lab Sci 35: 161-8.
326. Xu, WL, Qiu, CX, Wahlin, A, Winblad, B, Fratiglioni, L. (2004) Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 63: 1181-6.
327. Yamaji, R, Okada, T, Moriya, M, Naito, M, Tsuruo, T, Miyatake, K, Nakano, Y. (1996) Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem 239: 494-500.
328. Yamasaki, M, Mishima, HK, Yamashita, H, Kashiwagi, K, Murata, K, Minamoto, A, Inaba, T. (2005) Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res 1050: 15-26.
329. Yano, M, Hasegawa, G, Ishii, M, Yamasaki, M, Fukui, M, Nakamura, N, Yoshikawa, T. (2004) Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep 9: 111-6.
330. Yasuda, Y, Masuda, S, Chikuma, M, Inoue, K, Nagao, M, Sasaki, R. (1998) Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 273: 25381-7.
331. You, Z, Saims, D, Chen, S, Zhang, Z, Guttridge, DC, Guan, KL, MacDougald, OA, Brown, AM, Evan, G, Kitajewski, J, Wang, CY. (2002) Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 157: 429-40.
332. Yu, YP, Xu, QQ, Zhang, Q, Zhang, WP, Zhang, LH, Wei, EQ. (2005) Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neurosci Lett 387: 5-10.
333. Yui, R, Matsuura, ET. (2006) Detection of deletions flanked by short direct repeats in mitochondrial DNA of aging Drosophila. Mutat Res 594: 155-61.
334. Zhang, F, Signore, AP, Zhou, Z, Wang, S, Cao, G, Chen, J. (2006) Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J Neurosci Res 83: 1241-51.
335. Zhang, SX, Ma, JX. (2007) Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 26: 1-37.
336. Zhang, Y, Park, TS, Gidday, JM. (2007) Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am J Physiol Heart Circ Physiol 292: H2573-81.
337. Zhao, Y, Wagner, F, Frank, SJ, Kraft, AS. (1995) The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony- stimulating factor receptor beta c chain. J Biol Chem 270: 13814-8.
338. Zheng, WH, Kar, S, Quirion, R. (2002) FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem 80: 1049-61.